Brett Zbar is a Managing Director at Foresite Capital, a healthcare-dedicated growth equity firm with over $1.2 billion under management. Brett joined Foresite Capital in 2015 with more than 15 years of healthcare private equity and industry experience. Prior to joining Foresite, Brett was a Partner at Aisling Capital. Over the course of more than a decade at Aisling Capital, Brett served as a member of the Board of Directors of Aragon Pharmaceuticals, Seragon Pharmaceuticals and Planet Biopharmaceuticals, and as a board observer at Catalent Pharma Solutions, among other companies. Previously, Brett was an Associate Principal at McKinsey & Company and a senior member of the Pharmaceuticals and Medical Products practice. Brett received his M.D. from Harvard Medical School and his B.A. from Yale College in English and Molecular Biophysics & Biochemistry.